Kangmei Pharma | 600518 - Assets


Kangmei Pharma reported CNY13.31B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Akebia Therapeutics USD 349.66M 12.86M Jun/2026
Alaunos Therapeutics USD 1.88M 1.08M Mar/2026
Avita Medical AUD 56.39M 1.74M Dec/2025
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Dianthus Therapeutics USD 1.21B 33.61M Jun/2026
Genomma Lab Internacional MXN 24.19B 605.51M Jun/2026
Hypermarcas BRL 26B 843.02M Mar/2026
Ionis Pharmaceuticals USD 2.99B 455.5M Jun/2026
IQVIA Holdings USD 29.88B 206M Jun/2026
Jiangsu Hengrui CNY 71.29B 1.43B Mar/2026
Kangmei Pharma CNY 13.31B 375.64M Mar/2026
Moderna USD 10.96B 527M Jun/2026
Organon & Co USD 13B 129M Mar/2026
Revvity USD 12.05B 49.24M Jun/2026
Sh Fosun Pharma CNY 122.97B 2.91B Mar/2026
Tectonic Therapeutic USD 246.58M 14.46M Mar/2026
Viatris USD 36.83B 358.5M Mar/2026
Wuxi Apptec CNY 116.26B 8.85B Jun/2026
Xeris Pharmaceuticals USD 392.01M 8.49M Mar/2026
Zz Pientze Pharmaceu CNY 18.38B 905.93M Mar/2026